Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography
- 15 November 2013
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 41 (4) , 714-722
Abstract
The literature suggests that a history of depression is associated with an increased risk of developing Alzheimer’s disease (AD). The aim of this study was to examine brain amyloid accumulation in patients with lifetime major depression using 18F-florbetapir (AV-45/Amyvid) PET imaging in comparison with that in nondepressed subjects. The study groups comprised 25 depressed patients and 11 comparison subjects who did not meet the diagnostic criteria for AD or amnestic mild cognitive impairment. Vascular risk factors, homocysteine and apolipoprotein E (ApoE) genotype were also examined. The standard uptake value ratio (SUVR) of each volume of interest was analysed using whole the cerebellum as the reference region. Patients with a lifetime history of major depression had higher 18F-florbetapir SUVRs in the precuneus (1.06 ± 0.08 vs. 1.00 ± 0.06, p = 0.045) and parietal region (1.05 ± 0.08 vs. 0.98 ± 0.07, p = 0.038) than the comparison subjects. Voxel-wise analysis revealed a significantly increased SUVR in depressed patients in the frontal, parietal, temporal and occipital areas (p < 0.01). There were no significant associations between global 18F-florbetapir SUVRs and prior depression episodes, age at onset of depression, or time since onset of first depression. Increased 18F-florbetapir binding values were found in patients with late-life major depression relative to comparison subjects in specific brain regions, despite no differences in age, sex, education, Mini Mental Status Examination score, vascular risk factor score, homocysteine and ApoE ε4 genotype between the two groups. A longitudinal follow-up study with a large sample size would be worthwhile.Keywords
This publication has 52 references indexed in Scilit:
- Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [18F]AV-45 Positron Emission Tomography in Chinese PopulationPLOS ONE, 2013
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environmentEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine, 2010
- Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent — a pilot studyNuclear Medicine and Biology, 2010
- Molecular polymorphism of Aβ in Alzheimer's diseaseNeurobiology of Aging, 2010
- Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individualsNeurobiology of Aging, 2010
- Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-BAlzheimer Disease & Associated Disorders, 2008
- Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activityProceedings of the National Academy of Sciences, 2007
- Depression and Risk for Alzheimer DiseaseArchives of General Psychiatry, 2006
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984